Tau phosphorylation (at AD-related site Ser396) and APP phosphorylation (at Thr668) were increased by Aβ oligomers incubation, which were also reversed by Chk1 inhibitors (Fig. 2f, g). Here, APP is linked to Alzheimer disease.